HK Stock Market Move | SR MEDICAL (00108) surged over 12% in early trading as the effectiveness of its AI-driven medical transformation becomes evident, with revenue in the first half of the year increasing by over 30% year-on-year.

SR MEDICAL (00108) rose by over 12% in early trading. As of the time of writing, it is up 9.18%, priced at HKD 2.2, with a trading volume of HKD 1.6118 million. According to the news, SR MEDICALs interim financial report shows that in the first half of 2026, SR MEDICAL achieved a total revenue of HKD 223 million, a year-on-year increase of approximately 30.7%. In terms of business structure, the company's smart medical services segment generated a revenue of HKD 65.576 million, while the property investment and management segment achieved a revenue of HKD 158 million. Notably, the smart medical services segment reported a profit of HKD 12.766 million in the first half of the year. Publicly available information reveals that in December last year, Guorui Groups Hong Kong-listed company, Guorui Life, acquired 78.3% of Chunyu Doctor for RMB 269 million. In July this year, Guorui Life, post-acquisition, was officially renamed "SR MEDICAL." With the official launch of "SR MEDICAL Technology," Guorui Group will deeply collaborate with its subsidiary industrial technology and asset management segments to extend Chunyu Doctor's digital medical service capabilities to a broader range of properties, communities, and cities.